About this trial
In this randomized controlled trial, study staff will randomize 130 Hispanic/Latino adults without dementia and over age 55 from Southern California and from Kaiser Permanente Washington (State) to either the culturally adapted De Pie physical activity intervention or an active comparison program focusing on general brain health topics. The purpose of this study is to determine if 12 weeks of the culturally adapted and fully remote De Pie y a Movernos intervention improves self-efficacy, habit strength, social support, and enjoyment for physical activity (PA), thus promoting adherence to moderate-intensity physical activity (MIPA) guidelines (150 minutes/week).
Eligibility criteria
This trial accepts healthy volunteersQualifiers
be 55-89 and self-identify as Hispanic/Latino(a)
able to participate for up to 20 weeks in the study
willing to be randomized to the intervention or active comparison program
willing to follow study procedures depending on program assignment
Disqualifiers
score less than or equal to 4 on the Six-Item Screener (Callahan et al., 2002)
unable to hear phone conversation, even with a hearing aid
planned surgeries or travel that would interfere with participation
had a fall in the last year that resulted in hospitalization
Trial design
Parallel
Treatments tested in this trial
De Pie Intervention
BehavioralParticipants are guided by a health coach trained in motivational interviewing through 6 biweekly phone sessions. Each session involves reviewing goals and problem-solving barriers from the prior 2 weeks experience; covering a topic related to Step 1 goals (or Step 2 goals if they pass the safety assessment) such as how to enjoy movement, social support, and using your surroundings; and setting goals and an action plan for the following two weeks.
Active Comparison Group: Healthy Actions And Lifestyles To Avoid Dementia (HALT-AD)
Other interventionThose in the active comparison program will receive no additional health coaching sessions. They will work through the HALT-AD content at their own pace, setting goals in the online platform as they go.
Treatment groups
Trial outcomes
Primary outcomes
Change in Moderate Intensity Physical Activity (MIPA) minutes/day
Time (minutes) spent being physically active during waking hours will be measured objectively by the ActiGraph worn for one week at Baseline and again after 12 weeks
Secondary outcomes
Meet MIPA guidelines of 150 minutes physical activity per week
Time (minutes) spent being physical active during waking hours will be measured objectively by the ActiGraph worn for one week at Baseline and again after 12 weeks
Average daily sedentary time
mins/day; ≤18 counts per 15s will be measured objectively by the ActiGraph worn for one week at baseline and again after 12 weeks.
Average daily light intensity physical activity (LPA)
mins/day; 19-518 counts per 15s will be measured objectively by the ActiGraph worn for one week at Baseline and again after 12 weeks
Average steps/day
Change in daily steps will be measured objectively by the ActiGraph worn for one week at Baseline and again after 12 weeks
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Kaiser Permanente
Lead sponsor
University of California, San Diego
Collaborator